However, since many of the compounds which induce synthetic lethality in cells with p53 mutations are involved in the DNA damage response, this strategy poses the danger of exacerbating genetic instability, which might even drive cancer growth and therapy resistance. This evidence concerns the gene TP53 and cancer.